Amphastar Pharmaceuticals Quarterly Income Statements Chart
Quarterly
|
Annual
Amphastar Pharmaceuticals Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| net revenues: | ||||||||||||||||||||||||||||||||||||||
| product revenues | 174,414,000 | 170,528,000 | 186,978,000 | 188,819,000 | 179,388,000 | 157,629,000 | 155,649,000 | 151,855,000 | ||||||||||||||||||||||||||||||
| other revenues | -455,000 | 2,395,000 | 3,006,000 | 14,207,000 | 22,456,000 | 28,701,000 | ||||||||||||||||||||||||||||||||
| total net revenues | 174,414,000 | 170,528,000 | 186,523,000 | 191,214,000 | 182,394,000 | 171,836,000 | 178,105,000 | 180,556,000 | ||||||||||||||||||||||||||||||
| | ||||||||||||||||||||||||||||||||||||||
| cost of revenues | 87,924,000 | 85,277,000 | 99,875,000 | 89,273,000 | 87,228,000 | 81,736,000 | 81,965,000 | 72,153,000 | 72,974,000 | 66,182,000 | 63,855,000 | 61,619,000 | 60,111,000 | 64,542,000 | 64,653,000 | 61,015,000 | 54,287,000 | 58,074,000 | 59,089,000 | 46,923,000 | 52,629,000 | 47,865,000 | 50,002,000 | 44,885,000 | 46,660,000 | 48,887,000 | 55,001,000 | 46,283,000 | 44,884,000 | 36,319,000 | 34,464,000 | |||||||
| gross profit | 86,490,000 | 85,251,000 | 86,648,000 | 101,941,000 | 95,166,000 | 90,100,000 | 96,140,000 | 108,403,000 | 72,738,000 | 73,840,000 | 71,168,000 | 58,510,000 | 63,356,000 | 55,826,000 | 56,234,000 | 51,183,000 | 47,376,000 | 44,946,000 | 36,832,000 | 36,508,000 | 33,177,000 | 36,823,000 | 33,381,000 | 35,252,000 | 32,387,000 | 30,903,000 | 34,689,000 | 29,260,000 | 26,156,000 | 31,714,000 | 24,902,000 | 33,171,000 | 17,578,000 | 13,318,000 | 13,280,000 | 11,960,000 | 11,791,000 | 14,996,000 |
| yoy | -9.12% | -5.38% | -9.87% | -5.96% | 30.83% | 22.02% | 35.09% | 85.27% | 14.81% | 32.27% | 26.56% | 14.32% | 33.73% | 24.21% | 52.68% | 40.20% | 42.80% | 22.06% | 10.34% | 3.56% | 2.44% | 19.16% | -3.77% | 20.48% | 23.82% | -2.56% | 39.30% | -11.79% | 48.80% | 138.13% | 87.52% | 177.35% | 49.08% | -11.19% | ||||
| qoq | 1.45% | -1.61% | -15.00% | 7.12% | 5.62% | -6.28% | -11.31% | 49.03% | -1.49% | 3.75% | 21.63% | -7.65% | 13.49% | -0.73% | 9.87% | 8.04% | 5.41% | 22.03% | 0.89% | 10.04% | -9.90% | 10.31% | -5.31% | 8.85% | 4.80% | -10.91% | 18.55% | 11.87% | -17.53% | 27.36% | -24.93% | 88.71% | 31.99% | 0.29% | 11.04% | 1.43% | -21.37% | |
| gross margin % | ||||||||||||||||||||||||||||||||||||||
| operating expenses: | ||||||||||||||||||||||||||||||||||||||
| selling, distribution, and marketing | 10,235,000 | 11,866,000 | 10,424,000 | 8,995,000 | 9,012,000 | 9,371,000 | 8,619,000 | 6,407,000 | 6,718,000 | 7,109,000 | 5,472,000 | 4,784,000 | 5,756,000 | 5,519,000 | 4,075,000 | 4,745,000 | 4,129,000 | 4,537,000 | 3,787,000 | 3,673,000 | 4,026,000 | 3,294,000 | 3,476,000 | 3,221,000 | 2,992,000 | 3,141,000 | 2,596,000 | 1,963,000 | 1,876,000 | 1,332,000 | 1,352,000 | 1,307,000 | 1,171,000 | 1,470,000 | 1,522,000 | 1,498,000 | 1,454,000 | 1,352,000 |
| general and administrative | 13,991,000 | 15,996,000 | 12,938,000 | 14,821,000 | 13,285,000 | 15,676,000 | 13,122,000 | 12,654,000 | 12,281,000 | 13,483,000 | 10,628,000 | 11,984,000 | 9,979,000 | 12,470,000 | 10,621,000 | 10,910,000 | 14,565,000 | 15,338,000 | 12,033,000 | 11,674,000 | 15,924,000 | 10,746,000 | 10,505,000 | 11,021,000 | 12,426,000 | 16,327,000 | 13,814,000 | 13,407,000 | 11,669,000 | 9,458,000 | 10,870,000 | 8,711,000 | 9,034,000 | 11,308,000 | 12,451,000 | 9,769,000 | 9,556,000 | 8,638,000 |
| research and development | 20,080,000 | 20,096,000 | 18,142,000 | 21,077,000 | 17,652,000 | 17,043,000 | 20,419,000 | 16,664,000 | 16,843,000 | 19,815,000 | 17,236,000 | 18,514,000 | 22,798,000 | 16,223,000 | 17,286,000 | 10,759,000 | 18,122,000 | 14,765,000 | 18,133,000 | 17,644,000 | 16,149,000 | 15,303,000 | 19,644,000 | 18,606,000 | 15,996,000 | 14,607,000 | 16,734,000 | 11,340,000 | 15,468,000 | 10,480,000 | 8,388,000 | 8,654,000 | 11,117,000 | 10,726,000 | 6,568,000 | 7,639,000 | 8,585,000 | 5,994,000 |
| total operating expenses | 44,306,000 | 47,958,000 | 41,504,000 | 44,893,000 | 39,949,000 | 42,090,000 | 42,160,000 | 35,725,000 | 35,842,000 | 40,407,000 | 33,336,000 | 35,282,000 | 38,533,000 | 34,212,000 | 31,982,000 | 26,414,000 | 36,816,000 | 34,640,000 | 33,953,000 | 32,991,000 | 36,099,000 | 29,343,000 | 33,625,000 | 32,848,000 | 31,414,000 | 34,075,000 | 33,144,000 | 26,710,000 | 29,013,000 | 21,384,000 | 20,827,000 | 18,800,000 | 21,326,000 | 23,578,000 | 20,541,000 | 18,984,000 | 19,608,000 | 16,168,000 |
| income from operations | 42,184,000 | 37,293,000 | 45,144,000 | 57,048,000 | 55,217,000 | 48,010,000 | 53,980,000 | 72,678,000 | 36,896,000 | 33,433,000 | 37,832,000 | 23,228,000 | 24,823,000 | 21,614,000 | 24,252,000 | 24,769,000 | 10,560,000 | 10,306,000 | 2,879,000 | 3,517,000 | -2,922,000 | 7,480,000 | -244,000 | 2,404,000 | 973,000 | -3,172,000 | 1,545,000 | 2,550,000 | -2,857,000 | 10,330,000 | 4,075,000 | 14,371,000 | -3,748,000 | -10,260,000 | -7,261,000 | -7,024,000 | -7,817,000 | -1,172,000 |
| yoy | -23.60% | -22.32% | -16.37% | -21.51% | 49.66% | 43.60% | 42.68% | 212.89% | 48.64% | 54.68% | 56.00% | -6.22% | 135.07% | 109.72% | 742.38% | 604.26% | -461.40% | 37.78% | -1279.92% | 46.30% | -400.31% | -335.81% | -115.79% | -5.73% | -134.06% | -130.71% | -62.09% | -82.26% | -23.77% | -200.68% | -156.12% | -304.60% | -52.05% | 775.43% | ||||
| qoq | 13.12% | -17.39% | -20.87% | 3.32% | 15.01% | -11.06% | -25.73% | 96.98% | 10.36% | -11.63% | 62.87% | -6.43% | 14.85% | -10.88% | -2.09% | 134.55% | 2.46% | 257.97% | -18.14% | -220.36% | -139.06% | -3165.57% | -110.15% | 147.07% | -130.67% | -305.31% | -39.41% | -189.25% | -127.66% | 153.50% | -71.64% | -483.43% | -63.47% | 41.30% | 3.37% | -10.14% | 566.98% | |
| operating margin % | ||||||||||||||||||||||||||||||||||||||
| non-operating expenses: | ||||||||||||||||||||||||||||||||||||||
| interest income | 1,921,000 | 2,089,000 | 2,292,000 | 2,427,000 | 3,337,000 | 2,556,000 | 2,303,000 | 1,202,000 | 1,030,000 | 924,000 | 580,000 | 331,000 | 229,000 | 181,000 | 157,000 | 141,000 | 142,000 | 161,000 | 130,000 | 161,000 | 198,000 | 153,000 | 256,000 | 450,000 | 143,000 | 148,000 | 121,000 | 105,000 | 106,000 | 50,000 | 74,000 | 75,000 | 83,000 | 65,000 | 92,000 | 89,000 | 94,000 | 32,000 |
| interest expense | -6,281,000 | -6,286,000 | -6,425,000 | -6,698,000 | -8,609,000 | -8,611,000 | -9,456,000 | -13,702,000 | -3,602,000 | -398,000 | -528,000 | -566,000 | -397,000 | -355,000 | -168,000 | -527,000 | -86,000 | -104,000 | -88,000 | -175,000 | -35,000 | -76,000 | -43,000 | -22,000 | -24,000 | -30,000 | -1,000 | -124,000 | -100,000 | -305,000 | -384,000 | -204,000 | -232,000 | -210,000 | -341,000 | 550,000 | -504,000 | -476,000 |
| other income (expenses) | 1,511,000 | -2,234,000 | 2,951,000 | -5,094,000 | 298,000 | 5,921,000 | -5,482,000 | 3,459,000 | -1,516,000 | -390,000 | 3,376,000 | -397,000 | -1,504,000 | 7,593,000 | 3,601,000 | 769,500 | 3,575,000 | 1,255,000 | 60,001,000 | -579,000 | -1,076,000 | 43,000 | -1,265,000 | |||||||||||||||
| total non-operating expenses | -2,849,000 | -6,431,000 | -1,675,000 | |||||||||||||||||||||||||||||||||||
| income before income taxes | 39,335,000 | 30,862,000 | 43,962,000 | 47,683,000 | 50,243,000 | 47,876,000 | 41,345,000 | 63,637,000 | 32,808,000 | 33,569,000 | 41,260,000 | 22,596,000 | 23,151,000 | 29,033,000 | 27,162,000 | 37,646,000 | 14,217,000 | 5,114,000 | -6,742,000 | 7,078,000 | -1,504,000 | 5,805,000 | 1,186,000 | 1,582,000 | 61,093,000 | -3,633,000 | 589,000 | 2,574,000 | -4,116,000 | 9,752,000 | 3,816,000 | 10,338,000 | -4,276,000 | -10,229,000 | -6,197,000 | -5,817,000 | -7,984,000 | -1,876,000 |
| income tax provision | 8,305,000 | 5,577,000 | 5,998,000 | 7,254,000 | 12,294,000 | 4,126,000 | 4,673,000 | 14,025,000 | 6,383,000 | 6,752,000 | 7,290,000 | 6,559,000 | 5,551,000 | 4,077,000 | 7,194,000 | 6,686,000 | 1,155,000 | 1,122,500 | 2,285,000 | |||||||||||||||||||
| income before equity in losses of unconsolidated affiliate | 31,030,000 | 25,285,000 | 37,964,000 | 40,429,000 | 37,949,000 | 43,750,000 | 36,672,000 | 49,612,000 | 26,425,000 | 26,817,000 | 33,970,000 | 16,037,000 | 17,600,000 | 24,956,000 | ||||||||||||||||||||||||
| equity in losses of unconsolidated affiliate | -573,000 | -505,000 | -390,000 | -301,000 | -785,000 | -57,000 | -163,000 | -254,000 | -703,000 | |||||||||||||||||||||||||||||
| net income | 31,030,000 | 25,285,000 | 37,964,000 | 40,429,000 | 37,949,000 | 43,177,000 | 36,167,000 | 49,222,000 | 26,124,000 | 26,032,000 | 33,913,000 | 15,874,000 | 17,346,000 | 24,253,000 | 19,760,000 | 30,960,000 | 8,622,000 | 3,959,000 | -5,792,000 | 4,793,000 | -1,429,000 | 3,525,000 | 755,000 | 984,000 | 46,920,000 | -2,154,000 | 1,718,000 | 1,616,000 | -2,790,000 | 6,895,000 | 2,489,000 | 7,533,000 | -3,008,000 | -6,647,000 | -665,000 | -2,521,000 | -5,379,000 | -1,180,000 |
| yoy | -18.23% | -41.44% | 4.97% | -17.86% | 45.26% | 65.86% | 6.65% | 210.08% | 50.61% | 7.34% | 71.62% | -48.73% | 101.18% | 512.60% | -441.16% | 545.94% | -703.36% | 12.31% | -867.15% | 387.09% | -103.05% | -263.65% | -56.05% | -39.11% | -1781.72% | -131.24% | -30.98% | -78.55% | -7.25% | -203.73% | -474.29% | -398.81% | -44.08% | 463.31% | ||||
| qoq | 22.72% | -33.40% | -6.10% | 6.54% | -12.11% | 19.38% | -26.52% | 88.42% | 0.35% | -23.24% | 113.64% | -8.49% | -28.48% | 22.74% | -36.18% | 259.08% | 117.78% | -168.35% | -220.84% | -435.41% | -140.54% | 366.89% | -23.27% | -97.90% | -2278.27% | -225.38% | 6.31% | -157.92% | -140.46% | 177.02% | -66.96% | -350.43% | -54.75% | 899.55% | -73.62% | -53.13% | 355.85% | |
| net income margin % | ||||||||||||||||||||||||||||||||||||||
| net income per share | ||||||||||||||||||||||||||||||||||||||
| basic | 0.66 | 0.53 | 0.79 | 0.83 | 0.77 | 0.9 | 0.75 | 1.01 | 0.54 | 0.54 | 0.7 | 0.32 | 0.35 | 0.5 | 0.41 | 0.62 | 0.16 | 0.11 | -0.13 | 0.08 | 0 | 0.09 | -0.02 | 0.03 | 1.01 | 0.02 | 0.04 | 0.05 | -0.06 | 0.15 | 0.06 | 0.17 | -0.07 | -0.15 | -10 | -50 | -120 | -30 |
| diluted | 0.64 | 0.51 | 0.74 | 0.78 | 0.73 | 0.81 | 0.69 | 0.91 | 0.49 | 0.5 | 0.65 | 0.3 | 0.33 | 0.47 | 0.4 | 0.59 | 0.16 | 0.1 | -0.13 | 0.08 | 46,753 | |||||||||||||||||
| weighted-average shares used for eps calculation | ||||||||||||||||||||||||||||||||||||||
| basic | 46,949 | 47,641 | 48,429 | 48,621 | 48,907 | 48,212 | 48,265 | 48,701 | 48,404 | 48,000 | 48,551 | 48,904 | 48,864 | 48,138 | 47,777 | 48,022 | 47,731 | 47,520 | 47,038 | 47,496 | 46,753 | 46,408 | 46,982 | 47,239 | 47,107 | 46,744 | 46,395 | 46,241 | 46,557 | 44,957 | 45,041 | 44,961 | 45,310 | 44,849 | 44,601,000 | 41,957,000 | 44,644,000 | 39,767,000 |
| non-operating income | ||||||||||||||||||||||||||||||||||||||
| total non-operating income (expenses) | -1,182,000 | -9,365,000 | -4,974,000 | -134,000 | -12,635,000 | -9,041,000 | -4,088,000 | 136,000 | 3,428,000 | -632,000 | -1,672,000 | 7,419,000 | 826,000 | 3,561,000 | 1,418,000 | 60,120,000 | -461,000 | -956,000 | 24,000 | -1,259,000 | ||||||||||||||||||
| net revenues | 145,712,000 | 140,022,000 | 135,023,000 | 120,129,000 | 123,467,000 | 120,368,000 | 120,887,000 | 112,198,000 | 101,663,000 | 103,020,000 | 95,921,000 | 83,431,000 | 85,806,000 | 84,688,000 | 83,383,000 | 80,137,000 | 79,047,000 | 79,790,000 | 89,690,000 | 75,543,000 | 71,040,000 | 68,033,000 | 59,366,000 | 76,912,000 | 63,868,000 | 53,853,000 | 56,886,000 | 55,877,000 | 59,711,000 | 49,003,000 | ||||||||
| net income attributable to non-controlling interests | 1,412,000 | 855,000 | -1,082,000 | 481,000 | 874,000 | -1,237,000 | -424,000 | 1,781,000 | -326,000 | -867,000 | -3,022,000 | -149,000 | -773,000 | |||||||||||||||||||||||||
| net income attributable to amphastar pharmaceuticals, inc. | 33,913,000 | 15,874,000 | 17,346,000 | 24,253,000 | 19,760,000 | 29,548,000 | 7,767,000 | 5,041,000 | -6,273,000 | 3,919,000 | -192,000 | 3,949,000 | -1,026,000 | 1,310,000 | 47,787,000 | 868,000 | 1,867,000 | 2,389,000 | ||||||||||||||||||||
| non-operating income: | ||||||||||||||||||||||||||||||||||||||
| other income | 2,903,750 | 13,263,000 | -323,000 | 51,000 | -3,904,000 | -379,000 | 176,000 | 1,313,000 | 568,000 | 243,000 | -260,000 | |||||||||||||||||||||||||||
| total non-operating income | 2,835,500 | 12,877,000 | -578,000 | -259,000 | -4,033,000 | -528,000 | 31,000 | 1,064,000 | 1,207,000 | -167,000 | ||||||||||||||||||||||||||||
| non-operating (expenses) income: | ||||||||||||||||||||||||||||||||||||||
| total non-operating (expenses) income | 3,657,000 | -5,192,000 | 1,430,000 | -822,000 | ||||||||||||||||||||||||||||||||||
| income tax benefit | 5,595,000 | -75,000 | 2,280,000 | 431,000 | 598,000 | 14,173,000 | -1,479,000 | -1,129,000 | 958,000 | -1,326,000 | 2,857,000 | 1,327,000 | 2,805,000 | -1,268,000 | -3,582,000 | -5,532,000 | -3,296,000 | -2,605,000 | -696,000 | |||||||||||||||||||
| other incomes | -5,249,000 | -1,752,000 | ||||||||||||||||||||||||||||||||||||
| net income per share | ||||||||||||||||||||||||||||||||||||||
| basic | 0.66 | 0.53 | 0.79 | 0.83 | 0.77 | 0.9 | 0.75 | 1.01 | 0.54 | 0.54 | 0.7 | 0.32 | 0.35 | 0.5 | 0.41 | 0.62 | 0.16 | 0.11 | -0.13 | 0.08 | 0 | 0.09 | -0.02 | 0.03 | 1.01 | 0.02 | 0.04 | 0.05 | -0.06 | 0.15 | 0.06 | 0.17 | -0.07 | -0.15 | -10 | -50 | -120 | -30 |
| diluted | 0.08 | -0.02 | 0.03 | 0.96 | 0.02 | 0.04 | 0.05 | -0.06 | 0.15 | 0.05 | 0.17 | -0.07 | -0.15 | -10 | -50 | -120 | -30 | |||||||||||||||||||||
| weighted-average shares used for eps calculation | ||||||||||||||||||||||||||||||||||||||
| basic | 46,949 | 47,641 | 48,429 | 48,621 | 48,907 | 48,212 | 48,265 | 48,701 | 48,404 | 48,000 | 48,551 | 48,904 | 48,864 | 48,138 | 47,777 | 48,022 | 47,731 | 47,520 | 47,038 | 47,496 | 46,753 | 46,408 | 46,982 | 47,239 | 47,107 | 46,744 | 46,395 | 46,241 | 46,557 | 44,957 | 45,041 | 44,961 | 45,310 | 44,849 | 44,601,000 | 41,957,000 | 44,644,000 | 39,767,000 |
| diluted | 48,248 | 49,907 | 50,075 | 49,894 | 50,416 | 46,395 | 48,281 | 46,557 | 45,968 | 46,810 | 44,961 | 45,310 | 44,849 | 44,601,000 | 41,957,000 | 44,644,000 | 39,767,000 | |||||||||||||||||||||
| other (expenses) income | 14,543,000 | -1,250,000 | ||||||||||||||||||||||||||||||||||||
| operating incomes: | ||||||||||||||||||||||||||||||||||||||
| gain on sale of intangible assets | ||||||||||||||||||||||||||||||||||||||
| impairment of long-lived assets | 114,000 | 217,000 | 128,000 | 4,000 | 74,000 | 78,000 | 13,000 | 184,000 | ||||||||||||||||||||||||||||||
| cost of revenue | 32,607,750 | 46,290,000 | 40,535,000 | 43,606,000 | 43,917,000 | 47,920,000 | 34,007,000 | |||||||||||||||||||||||||||||||
| net income per common share: | ||||||||||||||||||||||||||||||||||||||
| basic | 0.66 | 0.53 | 0.79 | 0.83 | 0.77 | 0.9 | 0.75 | 1.01 | 0.54 | 0.54 | 0.7 | 0.32 | 0.35 | 0.5 | 0.41 | 0.62 | 0.16 | 0.11 | -0.13 | 0.08 | 0 | 0.09 | -0.02 | 0.03 | 1.01 | 0.02 | 0.04 | 0.05 | -0.06 | 0.15 | 0.06 | 0.17 | -0.07 | -0.15 | -10 | -50 | -120 | -30 |
| diluted | 0.08 | -0.02 | 0.03 | 0.96 | 0.02 | 0.04 | 0.05 | -0.06 | 0.15 | 0.05 | 0.17 | -0.07 | -0.15 | -10 | -50 | -120 | -30 | |||||||||||||||||||||
| total other income | -704,000 |
We provide you with 20 years income statements for Amphastar Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Amphastar Pharmaceuticals stock. Explore the full financial landscape of Amphastar Pharmaceuticals stock with our expertly curated income statements.
The information provided in this report about Amphastar Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.